1 / 5

Country presentation - Uganda

Country presentation - Uganda. Presented by Juliet & Martin, September 2004. HIV/AIDS situation. Population about 26 million 1 – 1.2 million affected About 100,000 – 120,000 need ART < 20,000 currently access ARVs A multisectoral approach to HIV/AIDS control and management used.

deana
Télécharger la présentation

Country presentation - Uganda

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Country presentation - Uganda Presented by Juliet & Martin, September 2004

  2. HIV/AIDS situation • Population about 26 million • 1 – 1.2 million affected • About 100,000 – 120,000 need ART • < 20,000 currently access ARVs • A multisectoral approach to HIV/AIDS control and management used

  3. Drugs available and used in the country • About fifty products currently registered • Lamivudine + Stavudine + Nevirapine • Lamivudine + Stavidine + !!! • Efivarenz, kaletra, Nelfinavir, ddl, AZT • Co trimoxazole prophylaxis encouraged

  4. HIV/AIDS management tools • Policy on HIV/AIDS management available • Accreditation criteria used to select facilities involved in HIV/AIDS management • Treatment guidelines for the management of HIV/AIDS present for both adults and children under five • Information to the public availed through all forms of media and IEC materials, NGOs, CBHW, PLWHA • Safety largely through product quality assessment and reports from clinicians, other HW & CBHW • Until recently reports were sent to the JCRC, this is being reviewed. The NDA & the ACP at the MoH to take lead in pharmacovigillance

  5. thank you

More Related